Intensive Course for Healthy Longevity
This isn't a typical lecture series; it's your doorway to immersive conversations with the world's leading academics and entrepreneurs.
Elevate your career in healthy longevity
The 2027 Intensive Course is scheduled for 22-24 February 2027, on NUS Campus.
Course Details
Dates
22 - 24 February 2027
Time
09:00 am - 18:00 pm
Course Fee
SGD $3500 (inclusive of GST);
Participants to also receive free access to Geromedicine Conference held on 25th & 26th February
Maximum Class Size
150 participants
Certification and Credits
Participants will receive a Certificate of Attendance.
CME points (12 points)
Admission Requirements
Qualifications
A minimum of Bachelor’s degree in Biology, Biomedical Sciences, Physical Sciences, Computer Science, Medicine, Healthcare, Education, and relevant fields.
Status
At least 3 years of work experience
Faculty 2027
Prof. J. J. (Hans) Meij, PhD, MBA
Professor J. J. (Hans) Meij serves as Chairperson of BEYOND100, a pioneering healthy longevity and wellbeing initiative launched by GEMS Education in Dubai, United Arab Emirates. The initiative integrates longevity science, preventive health and evidence-based lifestyle practices into education, promoting lifelong health and wellbeing from an early age.
He is also Co-Founder of the NUS Academy for Healthy Longevity and Visiting Professor at the National University of Singapore, bringing more than 45 years of international experience spanning healthcare, academia and healthy longevity research.
A medical anthropologist by training, Prof. Meij's research has explored the genetic and evolutionary determinants of healthy ageing, including pioneering studies involving populations in rural Ghana. His work spans Africa, Europe, the United States and Australia, examining how biology, environment and health systems influence ageing across diverse populations.
At NUS, Prof. Meij contributes to healthy longevity education and research translation through programmes including the Healthy Longevity Intensive Course and Healthy Longevity Talent Incubator, helping bridge scientific advances with real-world applications in healthcare, education and society.
.
Prof. Andrea B. Maier, MD, PhD
Awarded an Oon Chiew Seng Professor in Medicine and Co-Founder and Director of the NUS Academy for Healthy Longevity, and Professor of Gerontology at Vrije Universiteit Amsterdam, Prof Maier is a physician-scientist and specialist in internal medicine-geriatric medicine. Her work focuses on geroscience and precision geromedicine, translating the biology of ageing into evidence-based approaches to extend healthspan.
Prof. Maier has authored more than 500 peer-reviewed publications spanning the biology of ageing, biomarkers, gerodiagnostics, gerotherapeutics and interventions to preserve health and function across the lifespan. Her research examines why individuals age at different rates and how biological, clinical and digital measures can be used to identify and target mechanisms of ageing at an individual level.
At NUS, she leads multidisciplinary research and clinical translation in healthy longevity, including the development and evaluation of precision geromedicine approaches through clinical trials. Before joining NUS, she held senior academic and clinical leadership roles in Australia and the Netherlands, including Professor of Medicine and Aged Care at the University of Melbourne and Divisional Director of Medicine and Community Care at the Royal Melbourne Hospital.
Prof. Maier advises international organisations working to advance healthy ageing and longevity, including the World Health Organization and Hevolution, and serves on the Board of the Academy for Health and Lifespan Research. She is the past Founding President of the Healthy Longevity Medicine Society and has co-founded initiatives spanning research, education and clinical translation, with a focus on moving longevity science from discovery towards evidence-based application.
Prof. Heike A. Bischoff-Ferrari, MD, DrPhD
Chair of Geriatrics at the University of Basel and leads the University Department of Acute Aging Medicine FELIX PLATTER, Prof Heike physician-scientist with specialist training in geriatric medicine, general internal medicine and rehabilitation, she holds Master's and doctoral degrees from the Harvard School of Public Health and has built an international research career focused on healthy longevity and the prevention of age-related functional decline.
Prof. Bischoff-Ferrari is the coordinating principal investigator of DO-HEALTH, a major European clinical trial and biobank investigating interventions to support healthy longevity. The study examines multiple dimensions of ageing; including phenotypic, functional and biological ageing, and has established an extensive network of researchers across Europe and the United States.
From 2013 to 2024, she established the first Academic Clinic on Geriatric Medicine and the first Chair of Geriatrics and Aging Research at the University of Zurich. In 2025, she founded the Swiss Campus for Healthy Longevity at the University of Basel, which also serves as the headquarters of the DO-HEALTH trial and biobank, further advancing the translation of healthy longevity research into clinical practice.
Prof. Bischoff-Ferrari is a member of the WHO Clinical Consortium on Healthy Ageing and the Academy of Health and Lifespan Research. She also co-founded the Global Health Span Extension Consortium with international collaborators from Stanford University, Harvard and Monash University to advance the validation of novel biomarkers of ageing towards clinical application. Her work brings together clinical medicine, public health and ageing biology to develop and evaluate evidence-based approaches to extending healthy years of life.
Prof. Terrie E. Moffitt, MBE, PhD, FBA
Not only is she a professor of social development at both King's College, London, and
Nannerl Keohane University, as well as a professor of psychology at Duke University, Professor Moffitt is the associate director of the Dunedin Longitudinal Study, which follows a 1972 birth cohort in New Zealand, and is an elected fellow of the US National Academy of Medicine, Association of Psychological Science, American Society of Criminology, American Academy of Arts and Sciences, American Academy of Political & Social Sciences, the British Academy, and the UK Academy of Medical Sciences.
She also founded the Environmental Risk Longitudinal Twin Study (E-Risk), which follows a 1994 birth cohort in Britain.
Prof Moffitt's expertise lies in the areas of mental health, biological aging, and longitudinal research methods.
Her service includes major roles as member of the International Advisory Board of Bocconi University, chair of the Board on Behavioral, Cognitive and Sensory Sciences at the US National Academies of Sciences, chair of the National Institute on Aging’s Data-Monitoring Board for the Health and Retirement Study, and chair of the jury for the Klaus J. Jacobs Prize (Switzerland).
Moffitt is recipient of the Member of the Most Excellent Order of the British Empire, the Stockholm Prize, the Swiss Klaus Jacobs Prize, the NARSAD Ruane Prize, and the 2022 Grawemeyer Prize for her work on mental health, and the Matilda White Riley Award from the NIH for her work on aging.
She received her PhD in psychology at the University of Southern California, and completed her postdoctoral training at the UCLA Neuropsychiatric Institute.
Prof. Guido Kroemer, MD, PhD
Prof. Guido Kroemer is Professor at the Faculty of Medicine, Université Paris Cité, and Director of the Metabolism, Cancer and Immunity research team at INSERM. He also directs the Metabolomics and Cell Biology platforms at Gustave Roussy Comprehensive Cancer Center and serves as a Hospital Practitioner at Hôpital Européen Georges-Pompidou in Paris, France.
An internationally recognised researcher in ageing, cancer and inflammation, Prof. Kroemer investigates the biological mechanisms of cellular stress and death. His pioneering discoveries include the role of mitochondrial membrane permeabilisation in regulated cell death, the cytoprotective and anti-ageing effects of macroautophagy, and the importance of immunogenic cell death in anticancer treatments.
With over 1,800 scientific publications, more than 500,000 citations and an h-index of 320, Prof. Kroemer ranks among the world's most highly cited biomedical researchers. His contributions span leading scientific journals, including Cell, Nature, Nature Medicine and Science. He has also held founding Editor-in-Chief roles across several journals in cell biology, oncology and geromedicine, and currently serves as Editor-in-Chief of Seminars in Immunology.
Prof. Kroemer is a member of numerous prestigious scientific academies, including Academia Europaea, the German National Academy of Sciences Leopoldina and the European Molecular Biology Organization (EMBO). He is also the Founding President of the European Academy of Tumor Immunology and President of the European Network for Cancer Immunotherapy, reflecting his longstanding leadership in advancing biomedical research and international scientific collaboration.
Accommodation Recommendations
For international attendees:
The Ridge, NUS
17 Computing Drive, Singapore 119881
Book with Group Code "582"
Citadines Connect
1 Rochester Park, Singapore 139212
Quote ‘NUS Unlock Healthy Longevity Conference 2027’ for discounted rates.
Citadines Science Park
Geneo, Singapore 119316
Quote ‘NUS Unlock Healthy Longevity Conference 2027’ for discounted rates.
Venue
NUSS Della & Seng Gee Guild Hall,
9 Kent Ridge Dr,
Guild House Singapore 119241
